dapagliflozin
astrazeneca
['dapagliflozin']
 dapa-hf+ deliver dapagliflozin the risk of cv and all-cause , hf &amp; cv death/mi/stroke the benefits of dapagliflozin were observed in all regardless of ef sglt2i could be initiated in patients with a clinical diagnosis of hf ##esccongress #escrme 
Jefe Servicio Cardiología. Hospital Denia. Cardiólogo Hospital La Salud. TICs @SVCardio